CTI BIOPHARMA CORP (22) | Human Resources (9)

Browse by Subcategory

Recent Contracts

Amendment to Severance Agreement, by and between CTI BioPharma Corp. and James K. Fong, dated as of March 1, 2022 (Filed With SEC on March 4, 2022)
CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on June 7, 2021)
CTI BioPharma Corp. Director Compensation Policy (Filed With SEC on May 6, 2021)
Severance Agreement, by and between CTI BioPharma Corp. and James K. Fong, dated as of January 6, 2015 (Filed With SEC on March 4, 2022)
CTI BioPharma Corp. 2017 Equity Incentive Plan Stock Option Agreement (Filed With SEC on November 10, 2020)
Director Compensation Policy (Filed With SEC on March 13, 2020)
CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 17, 2019)
Director Compensation Policy (Filed With SEC on May 2, 2019)
CTI BioPharma Corp. Executive Incentive Compensation Plan (Filed With SEC on March 13, 2019)